97 related articles for article (PubMed ID: 9122396)
1. Relation of gastric distention to prostaglandin therapy in neonates.
Kriss VM; Desai NS
Radiology; 1997 Apr; 203(1):219-21. PubMed ID: 9122396
[TBL] [Abstract][Full Text] [Related]
2. Gastric thumbprinting: diffuse gastric wall mucosal and submucosal thickening in infants with ductal-dependent cyanotic congenital heart disease maintained on long-term prostaglandin therapy.
Joshi A; Berdon WE; Brudnicki A; LeQuesne G; Ruzal-Shapiro C; Hayes C
Pediatr Radiol; 2002 Jun; 32(6):405-8. PubMed ID: 12029339
[TBL] [Abstract][Full Text] [Related]
3. Gastric-outlet obstruction induced by prostaglandin therapy in neonates.
Peled N; Dagan O; Babyn P; Silver MM; Barker G; Hellmann J; Scolnik D; Koren G
N Engl J Med; 1992 Aug; 327(8):505-10. PubMed ID: 1635565
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin induced cortical hyperostosis in neonates with cyanotic heart disease.
Nadroo AM; Shringari S; Garg M; al-Sowailem AM
J Perinat Med; 2000; 28(6):447-52. PubMed ID: 11155430
[TBL] [Abstract][Full Text] [Related]
5. Cortical hyperostosis in an infant on prolonged prostaglandin infusion: case report and literature review.
Velaphi S; Cilliers A; Beckh-Arnold E; Mokhachane M; Mphahlele R; Pettifor J
J Perinatol; 2004 Apr; 24(4):263-5. PubMed ID: 15067299
[TBL] [Abstract][Full Text] [Related]
6. Combined prostaglandin therapy and ductal formalin infiltration in neonatal pulmonary oligemia.
Larson JE; Fleming WH; Sarafian LB; Rogler WC; Hofschire PJ; McManus BM
J Thorac Cardiovasc Surg; 1985 Dec; 90(6):907-11. PubMed ID: 4068741
[TBL] [Abstract][Full Text] [Related]
7. [Prostaglandin E1 in newborn infants with ductus-dependent heart diseases. Review of 40 cases].
Simões LC; Sarachaga IH; Quero M; Casanova M; Cazzaniga M; Villibre D
Arq Bras Cardiol; 1985 Jul; 45(1):31-6. PubMed ID: 3938651
[No Abstract] [Full Text] [Related]
8. [Complications of prostaglandin E1 treatment of congenital heart disease in paediatric medical intensive care].
Lucron H; Chipaux M; Bosser G; Le Tacon S; Lethor JP; Feillet F; Burger G; Monin P; Marçon F
Arch Mal Coeur Vaiss; 2005 May; 98(5):524-30. PubMed ID: 15966603
[TBL] [Abstract][Full Text] [Related]
9. Study of low dosage prostaglandin--usages and complications.
Singh GK; Fong LV; Salmon AP; Keeton BR
Eur Heart J; 1994 Mar; 15(3):377-81. PubMed ID: 8013512
[TBL] [Abstract][Full Text] [Related]
10. Side-effects of long-term prostaglandin E(1) treatment in neonates.
Tálosi G; Katona M; Túri S
Pediatr Int; 2007 Jun; 49(3):335-40. PubMed ID: 17532831
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of clinical diagnosis and decision to commence intravenous prostaglandin E1 in neonates presenting with hypoxemia in a transport setting.
Shivananda S; Kirsh J; Whyte HE; Muthalally K; McNamara PJ
J Crit Care; 2010 Mar; 25(1):174.e1-9. PubMed ID: 19577418
[TBL] [Abstract][Full Text] [Related]
12. Cortical hyperostosis: a complication of prostaglandin E1 treatment in congenital heart disease.
Smet MH; Marchal G; Lambert L; Devlieger H; Gewillig M
J Belge Radiol; 1989 Oct; 72(5):377-80. PubMed ID: 2600053
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
[TBL] [Abstract][Full Text] [Related]
14. Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease.
Høst A; Halken S; Andersen PE
Pediatr Radiol; 1988; 18(2):149-53. PubMed ID: 3281113
[TBL] [Abstract][Full Text] [Related]
15. [Use of prostaglandins in neonatal cardiology].
Dinarević S; Kurtagić S; Maksić H
Med Arh; 2000; 54(5-6):279-82. PubMed ID: 11219904
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E1 treatment in ductus dependent congenital cardiac malformation. A review of the treatment of 34 neonates.
Høst A; Halken S; Kamper J; Lillquist K
Dan Med Bull; 1988 Feb; 35(1):81-4. PubMed ID: 3342648
[TBL] [Abstract][Full Text] [Related]
17. Enteral feeding in prostaglandin-dependent neonates: is it a safe practice?
Willis L; Thureen P; Kaufman J; Wymore E; Skillman H; da Cruz E
J Pediatr; 2008 Dec; 153(6):867-9. PubMed ID: 19014824
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Prostaglandin E1 Infusion for Newborns with Critical Congenital Heart Disease.
Aykanat A; Yavuz T; Özalkaya E; Topçuoğlu S; Ovalı F; Karatekin G
Pediatr Cardiol; 2016 Jan; 37(1):131-4. PubMed ID: 26260095
[TBL] [Abstract][Full Text] [Related]
19. Transporting newborn infants with suspected duct dependent congenital heart disease on low-dose prostaglandin E1 without routine mechanical ventilation.
Browning Carmo KA; Barr P; West M; Hopper NW; White JP; Badawi N
Arch Dis Child Fetal Neonatal Ed; 2007 Mar; 92(2):F117-9. PubMed ID: 16905574
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin therapy at the local level for neonates with critical heart defects.
Zellers TM; Gutgesell HP
Va Med; 1986 Mar; 113(3):162-4. PubMed ID: 3705715
[No Abstract] [Full Text] [Related]
[Next] [New Search]
